Subscribe to Newsletter

Nitrosamines Risk Mitigation:

This study highlights the benefits of incorporating Recombinant Insulin in hiPSC culture to enhance the quality and productivity of these cells while maintaining their stability. The addition of Recombinant Insulin to the culture media resulted in improved cell morphology, proliferation, and attachment, indicating better cell culture performance. These improvements were observed even at a low insulin concentration (5 mg/L). Moreover, the pluripotency markers remained unaltered following the addition of Recombinant Insulin, indicating that it does not affect the stability of hiPSCs in culture. These findings suggest that using Recombinant Insulin as an ingredient in the formulation of cell culture media can improve the consistency and reliability of hiPSC production, ultimately enhancing the quality of regenerative medicine drug products.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Login
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register